Timothy Madsen Robinson, OD - Medicare Optometrist in Newcastle, WY

Timothy Madsen Robinson, OD is a medicare enrolled "Optometrist" provider in Newcastle, Wyoming. He went to Pacific University - College Of Optometry and graduated in 2012 and has 12 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Kathryn O Haivala Od Pllc and his current practice location is 101 S Railway Ave, Newcastle, Wyoming. You can reach out to his office (for appointments etc.) via phone at (307) 746-2371.

Timothy Madsen Robinson is licensed to practice in Wyoming (license number 344T) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1730442997.

Contact Information

Timothy Madsen Robinson, OD
101 S Railway Ave,
Newcastle, WY 82701-2814
(307) 746-2371
Not Available



Healthcare Provider's Profile

Full NameTimothy Madsen Robinson
GenderMale
SpecialityOptometry
Experience12 Years
Location101 S Railway Ave, Newcastle, Wyoming
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Timothy Madsen Robinson attended and graduated from Pacific University - College Of Optometry in 2012
  NPI Data:
  • NPI Number: 1730442997
  • Provider Enumeration Date: 06/21/2012
  • Last Update Date: 09/05/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 1254589229
  • Enrollment ID: I20160906001165

Medical Identifiers

Medical identifiers for Timothy Madsen Robinson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1730442997NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 344T (Wyoming)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Kathryn O Haivala Od Pllc39719229152

News Archive

Recent CE Mark approvals expand St. Jude Medical's MRI-compatible device portfolio in Europe

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads, allowing existing or future patients with these technologies to undergo magnetic resonance imaging (MRI) scans without compromising device performance.

Fathers can protect their LGB kids from negative effects of discrimination on health

Lesbian, gay, and bisexual individuals who report being discriminated against but who feel close to their fathers have lower levels of C-reactive protein-a measure of inflammation and cardiovascular risk-than those without support from their fathers, finds a new study from researchers at NYU College of Global Public Health.

Forest Pharmaceuticals to pay $300 million as penalty for criminal actions

The U.S. Food and Drug Administration (FDA), working in close coordination with the U.S. Department of Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered into a plea agreement in which the company accepted responsibility for criminal actions including distribution of an unapproved new drug, distribution of a misbranded drug, and obstruction of an FDA inspection.

Sheffield researchers use JPK's NanoWizard AFM systems to study soft matter, biological systems at molecular scale

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, works closely with users at the University of Sheffield where their NanoWizard AFM systems are being used to further understand soft matter and biological systems at the molecular scale in the Hobbs SPM Group in the Department of Physics.

CTI BioPharma announces upcoming presentations of pacritinib data at ASH Annual Meeting

CTI BioPharma Corp. (CTI) today announced the upcoming presentations of data highlighting pacritinib, an oral multikinase inhibitor with dual activity against JAK2 and FLT3, and tosedostat, an oral selective inhibitor of aminopeptidases, at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 6-9 in San Francisco, CA.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Timothy Madsen Robinson allows following entities to bill medicare on his behalf.
Provider NameKathryn O Haivala Od Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1548874084
PECOS PAC ID: 3971922915
Enrollment ID: O20200924002764

News Archive

Recent CE Mark approvals expand St. Jude Medical's MRI-compatible device portfolio in Europe

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads, allowing existing or future patients with these technologies to undergo magnetic resonance imaging (MRI) scans without compromising device performance.

Fathers can protect their LGB kids from negative effects of discrimination on health

Lesbian, gay, and bisexual individuals who report being discriminated against but who feel close to their fathers have lower levels of C-reactive protein-a measure of inflammation and cardiovascular risk-than those without support from their fathers, finds a new study from researchers at NYU College of Global Public Health.

Forest Pharmaceuticals to pay $300 million as penalty for criminal actions

The U.S. Food and Drug Administration (FDA), working in close coordination with the U.S. Department of Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered into a plea agreement in which the company accepted responsibility for criminal actions including distribution of an unapproved new drug, distribution of a misbranded drug, and obstruction of an FDA inspection.

Sheffield researchers use JPK's NanoWizard AFM systems to study soft matter, biological systems at molecular scale

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, works closely with users at the University of Sheffield where their NanoWizard AFM systems are being used to further understand soft matter and biological systems at the molecular scale in the Hobbs SPM Group in the Department of Physics.

CTI BioPharma announces upcoming presentations of pacritinib data at ASH Annual Meeting

CTI BioPharma Corp. (CTI) today announced the upcoming presentations of data highlighting pacritinib, an oral multikinase inhibitor with dual activity against JAK2 and FLT3, and tosedostat, an oral selective inhibitor of aminopeptidases, at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 6-9 in San Francisco, CA.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Timothy Madsen Robinson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Timothy Madsen Robinson, OD
Po Box 614,
Newcastle, WY 82701-0614

Ph: (605) 929-7633
Timothy Madsen Robinson, OD
101 S Railway Ave,
Newcastle, WY 82701-2814

Ph: (307) 746-2371

News Archive

Recent CE Mark approvals expand St. Jude Medical's MRI-compatible device portfolio in Europe

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads, allowing existing or future patients with these technologies to undergo magnetic resonance imaging (MRI) scans without compromising device performance.

Fathers can protect their LGB kids from negative effects of discrimination on health

Lesbian, gay, and bisexual individuals who report being discriminated against but who feel close to their fathers have lower levels of C-reactive protein-a measure of inflammation and cardiovascular risk-than those without support from their fathers, finds a new study from researchers at NYU College of Global Public Health.

Forest Pharmaceuticals to pay $300 million as penalty for criminal actions

The U.S. Food and Drug Administration (FDA), working in close coordination with the U.S. Department of Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered into a plea agreement in which the company accepted responsibility for criminal actions including distribution of an unapproved new drug, distribution of a misbranded drug, and obstruction of an FDA inspection.

Sheffield researchers use JPK's NanoWizard AFM systems to study soft matter, biological systems at molecular scale

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, works closely with users at the University of Sheffield where their NanoWizard AFM systems are being used to further understand soft matter and biological systems at the molecular scale in the Hobbs SPM Group in the Department of Physics.

CTI BioPharma announces upcoming presentations of pacritinib data at ASH Annual Meeting

CTI BioPharma Corp. (CTI) today announced the upcoming presentations of data highlighting pacritinib, an oral multikinase inhibitor with dual activity against JAK2 and FLT3, and tosedostat, an oral selective inhibitor of aminopeptidases, at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 6-9 in San Francisco, CA.

Read more News

› Verified 6 days ago


Optometrist in Newcastle, WY

Newcastle Vision Clinic Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 101 S Railway Ave, Newcastle, WY 82701
Phone: 307-746-2371    Fax: 307-746-2195
Kiana Marie Ehlers,
Optometrist
Medicare: Medicare Enrolled
Practice Location: 101 S Railway Ave, Newcastle, WY 82701
Phone: 307-746-2371    Fax: 307-746-2195

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.